Mitoxantrone and high dose Ara-C for the treatment of ANLL in childhood: a pilot study of the EORTC CLCG (EORTC 58 872)

MLA

C, Béhar, et al. “Mitoxantrone and High Dose Ara-C for the Treatment of ANLL in Childhood: A Pilot Study of the EORTC CLCG (EORTC 58 872).” Leukemia, vol. 6, Jan. 1992. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........144495781f32cc50aa6a8b7275b9135b&authtype=sso&custid=ns315887.

APA

C, B., Y, B., H, R., E, V., A, B., P, B., P, B., G, S., S, S., & A, R. (1992). Mitoxantrone and high dose Ara-C for the treatment of ANLL in childhood: a pilot study of the EORTC CLCG (EORTC 58 872). Leukemia, 6.

Chicago

C, Béhar, Bertrand Y, Rubie H, Vilmer E, Babin A, Brock P, Boutard P, Solbu G, Suciu S, and Robert A. 1992. “Mitoxantrone and High Dose Ara-C for the Treatment of ANLL in Childhood: A Pilot Study of the EORTC CLCG (EORTC 58 872).” Leukemia 6 (January). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........144495781f32cc50aa6a8b7275b9135b&authtype=sso&custid=ns315887.